Platform Therapeutic Education in Heart Failure and Coronary Disease
NCT ID: NCT01869452
Last Updated: 2015-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
555 participants
INTERVENTIONAL
2010-05-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Education Strategy for Patients With Acute Heart Failure
NCT03035123
Heart Failure Educational and Follow up Platform
NCT02110433
ETIC (Therapeutic Education in Heart Failure)
NCT01065142
Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure
NCT07023536
Telematic Educational Intervention in Patients With Heart Failure.
NCT07317882
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Quality of life and patient's knowledge are regularly evaluated through questionnaires
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
therapeutic education class 1
patients in class 1 will have a follow up call with therapeutic education every 3 months. this is the light follow up.
therapeutic education
knowledge of disease, risk factors, diet, medication, alert symptoms
therapeutic education class 2
patients in class 2 will have a follow up call with therapeutic education every month. this is the moderate follow up
therapeutic education
knowledge of disease, risk factors, diet, medication, alert symptoms
therapeutic education class 3
patients in class 3 will have a follow up call with therapeutic education twice a month. this is the heavy follow up.
therapeutic education
knowledge of disease, risk factors, diet, medication, alert symptoms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
therapeutic education
knowledge of disease, risk factors, diet, medication, alert symptoms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalization for heart failure
* acute coronary syndrome \< 3 months
* heart failure \< 3 months
* coronary by-pass surgery \< 3 months
Exclusion Criteria
* valvular cardiac pathology
* obstructive cardiomyopathy
* planned cardiac transplantation
* severe neurological or psychiatric troubles
* loss of autonomy
* other (refusal, language, nursing house, way of life not compatible with follow up, refusal of telephonic contacts)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
union nationale de formation et d'evaluation en medecine cardio-vasculaire
UNKNOWN
Resicard
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pr Ariel Cohen
head of the departement of cardiology,Saint Antoine hospital , Paris
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ariel a cohen, md
Role: PRINCIPAL_INVESTIGATOR
Resicard
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Coeur Effort Sante
Paris, , France
Clinique Turin
Paris, , France
Hopital Saint Antoine
Paris, , France
Centre Cardiologique Alfred Kastler
Sarcelles, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Platform
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.